Cargando…
Association of Hepatic Lipase -514T Allele with Coronary Artery Disease and Ankle-Brachial Index, Dependence on the Lipoprotein Phenotype: The GENES Study
OBJECTIVES: Relationship between hepatic lipase (LIPC) polymorphism and coronary artery disease (CAD) has often led to contradictory results. We studied this relation by genotyping rs1800588 in the LIPC promoter in a case-control study on CAD (the GENES study). We also investigated the relationship...
Autores principales: | Verdier, Céline, Ruidavets, Jean-Bernard, Bongard, Vanina, Taraszkiewicz, Dorota, Martinez, Laurent O., Elbaz, Meyer, Ferrières, Jean, Perret, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706445/ https://www.ncbi.nlm.nih.gov/pubmed/23874450 http://dx.doi.org/10.1371/journal.pone.0067805 |
Ejemplares similares
-
Ineffective Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Monotherapy in Dyslipidemia with Low-Density Lipoprotein Cholesterol (LDL-C) Receptor Abnormalities: A Report of 2 Cases
por: Matta, Anthony, et al.
Publicado: (2020) -
Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study
por: Genoux, Annelise, et al.
Publicado: (2016) -
Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis
por: Matta, Anthony, et al.
Publicado: (2021) -
Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease
por: Faccini, Julien, et al.
Publicado: (2017) -
14-Year Risk of All-Cause Mortality According to Hypoglycaemic Drug Exposure in a General Population
por: Bérard, Emilie, et al.
Publicado: (2014)